Published 10 days ago • loading... • Updated 10 days ago

VistaGen Therapeutics (NASDAQ:VTGN) Earns "Outperform" Rating from William Blair

Summary by marketbeat.com

William Blair reiterated an "outperform" rating on shares of VistaGen Therapeutics in a report on Wednesday.

1 Articles

All

Left

Center

Right

William Blair reiterated an "outperform" rating on shares of VistaGen Therapeutics in a report on Wednesday.

10 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated10 days agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in 10 days ago on Thursday, June 19, 2025.

Sources are mostly out of (0)